Back to Browse Journals » Vascular Health and Risk Management » Volume 5

Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers

Authors Luca Masotti, Marc Righini, Nicolas Vuilleumier, Fabio Antonelli, et al.

Published Date July 2009 Volume 2009:5 Pages 567—575

DOI http://dx.doi.org/10.2147/VHRM.S4861

Published 2 July 2009

Luca Masotti1, Marc Righini2, Nicolas Vuilleumier3, Fabio Antonelli4, Giancarlo Landini5, Roberto Cappelli6, Patrick Ray7

1Internal Medicine, 4Clinical Chemistry, Cecina Hospital, Cecina, Italy; 2Division of Angiology and Haemostasis, Department of Internal Medicine, Geneva University Hospital, Switzerland; 3Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals and University of Geneva, Switzerland; 5Internal Medicine, Santa Maria Nuova Hospital, Florence, Italy; 6Thrombosis Center, University of Siena, Siena, Italy; 7Department of Emergency Medicine, Centre Hospitalo-Universitaire Pitié-Salpêtrière, UPMC Paris 6, Paris, France

Abstract: Pulmonary embolism (PE) represents a common disease in emergency medicine and guidelines for diagnosis and treatment have had wide diffusion. However, PE morbidity and mortality remain high, especially when associated to hemodynamic instability or right ventricular dysfunction. Prognostic stratification to identify high risk patients needing to receive more aggressive pharmacological and closer monitoring is of utmost importance. Modern guidelines for management of acute PE are based on risk stratification using either clinical, radiological, or laboratory findings. This article reviews the modern treatment of acute PE, which is customized upon patient prognosis. Accordingly the current risk stratification tools described in the literature such as clinical scores, echocardiography, helical computer tomography, and biomarkers will be reviewed.

Keywords: pulmonary embolism, prognosis, troponin, BNP, NT-proBNP, echocardiography, computer tomography

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation

Luca Masotti, Patrick Ray, Marc Righini, Gregoire Le Gal, Fabio Antonelli, et al

Vascular Health and Risk Management 2008, 4:629-636

Published Date: 30 June 2008

Readers of this article also read:

Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions

Sun DQ, Wei XB, Xue X, Fang ZJ, Ren MR, Lou HY, Zhang XM

International Journal of Nanomedicine 2014, 9:3413-3423

Published Date: 18 July 2014

REACH, animal testing, and the precautionary principle

Menache A, Nastrucci C

Medicolegal and Bioethics 2012, 2:13-29

Published Date: 6 August 2012

The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals

Men Y, Wang XX, Li RJ, Zhang Y, Tian W, Yao HJ, Ju RJ, Ying X, Zhou J, Li N, Zhang L, Yu Y, Lu WL

International Journal of Nanomedicine 2011, 6:3125-3137

Published Date: 2 December 2011

Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes

Magnus Dencker, Martin Stagmo, Mozhgan Dorkhan

Vascular Health and Risk Management 2010, 6:373-382

Published Date: 18 May 2010

Dronedarone for atrial fibrillation: a new therapeutic agent

Pawan D Patel, Rohit Bhuriya, Dipal D Patel, et al

Vascular Health and Risk Management 2009, 5:635-642

Published Date: 5 August 2009

Irbesartan improves arterial compliance more than lisinopril

Khalid Ali, Chakravarthi Rajkumar, Francesco Fantin, Rebekah Schiff, Christopher J Bulpitt

Vascular Health and Risk Management 2009, 5:587-592

Published Date: 13 July 2009

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives

Madhuri Devabhaktuni, Sripal Bangalore

Vascular Health and Risk Management 2009, 5:377-387

Published Date: 27 April 2009

Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention

Arijit Dasgupta, Debabrata Mukherjee

Vascular Health and Risk Management 2009, 5:275-286

Published Date: 19 March 2009

Recognition of transorbital intracranial injury ||FREE PAPER||

Roger E Turbin, Flora Levin, Dawn N Maxwell

Clinical Ophthalmology 2007, 1:85-89

Published Date: 18 June 2007